Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization

American Journal of Roentgenology

Volumn 195, Issue 5, 2010, Pages 1220-1230

  Monsky, Wayne L ^a   Kim, Isaac ^b   Loh, Shaun ^a   Li, Chin Shang ^b   Greasby, Tamara A ^c   Deutsch, Larry Stuart ^a   Badawi, Ramsey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemoembolization; Ethiodol; Necrosis; Tumor; Volumetric CT

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; AUTOMATION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; TIME; TUMOR NECROSIS; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AUTOMATION; CARCINOID TUMOR; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; ETHIODIZED OIL; FEMALE; HUMANS; INSULINOMA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; PILOT PROJECTS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOFTWARE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78649703798     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.09.3964     Document Type: Article

References (42)

1. Sharma KV, Gould JE, Harbour JW, et al. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR 2008; 190:99-104
2. Ho AS, Picus J, Darcy MD. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR 2007; 188:1201-1207 (Pubitemid 46668497)
3. Alba E, Valls C, Dominguez J, et al. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. AJR 2008; 190:1341-1358
4. Yamane B, Weber S. Liver-directed treatment modalities for primary and secondary hepatic tumors. Surg Clin North Am 2009; 89:97-113
5. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171
6. Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 18:359:1734-1739
7. Hunt SJ, Yu W, Wientraub J, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast enhanced cross sectional imaging with histopathologic correlation. J Vasc Interv Radiol 2009; 20:30-38
8. Forner A, Ayuso C, Varela M, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are Response Evaluation Criteria in Solid Tumors reliable? Cancer 2009; 1:616-623
9. Bruix J, Sherman M, Llovet JM, et al.; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35:421-430
10. Eisenhauer EA, Therasse P, Bogaerts J, et al. New Response Evaluation Criteria in Solid Tumors: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-247
11. Matsuo N, Nishimine K, Uchida H, et al. Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma [in Japanese]. Jpn J Gastroenterol 1992; 89:1415-1425
12. Yu SC, Hui JW, Hui EP, et al. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with Lipiodol-ethanol mixture versus transcatheter arterial chemoembolization. J Vasc Interv Radiol 2009; 20:352-359
13. Fujita T, Ito K, Tanabe M, et al. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol 2008; 19:333-341 (Pubitemid 351273621)
14. Choi BI, Kim HC, Han JK, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathological findings. Radiology 1992; 182:709-713
15. Takayasu K, Arii S, Matsuo N, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR 2000; 175:699-704
16. Ray S, Hagge R, Gillen M, et al. Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics. Med Phys 2008; 35:5869-5881
17. Drever L, Robinson DM, McEwan A, et al. A local contrast based approach to threshold segmentation for PET target volume delineation. Med Phys 2006; 33:1583-1594
18. Solomon B, Soulen MC, Baum RA, et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999; 10:793-798
19. Fisher RA. Statistical methods for research workers, 12th ed. Edinburgh, Scotland: Oliver and Boyd, 1954
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8:307-310
21. Yohai VJ. High breakdown point and high efficiency robust estimates for regression. Ann Stat 1987; 15:642-656
22. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34:187-220
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481
24. Salem R, Thurston KG. Radioembolization with 90-yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1. Technical and methodologic considerations. J Vasc Interv Radiol 2006; 17:1251-1278 (Pubitemid 44259009)
25. Salem R, Thurston KG. Radioembolization with 90-yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2. Special topics. J Vasc Interv Radiol 2006; 17:1425-1439 (Pubitemid 44412994)
26. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 3. Comprehensive literature review and future direction. J Vasc Interv Radiol 2006; 17:1571-1593 (Pubitemid 44596135)
27. Cammà C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54
28. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37:429-442
29. Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 2005; 80[suppl 1]:S113-S119
30. Sargent DJ, Rubinstein L, Schwartz L, et al. Validation of novel imaging methodologies for use as cancer clinical trials end-points. Eur J Cancer 2009; 45:290-299
31. Chen G, Ma DQ, He W, et al. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14:5738-5743
32. Burzykowski M, Buyse M, Piccart-Gebhart MJ, et al. Evaluation of tumor response, disease control, progression-free survival and time to progression as potential surrogate end points in metastatic breast cancer. J Clin Oncol 2008; 26:1987-1992
33. Campadelli P, Casiraghi E, Esposito A. Liver segmentation from computed tomography scans: a survey and a new algorithm. Artif Intell Med 2009; 45:185-196
34. McNitt-Gray MF, Bidaut LM, Armato SG, et al. Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error. Transl Oncol 2009; 2:216-222
35. Zhao B, Schwartz LH, Jiang L, et al. Shape-constraint region growing for delineation of hepatic metastases on contrast-enhanced computed tomograph scans. Invest Radiol 2006; 41:753-762 (Pubitemid 44401302)
36. Salvi E, Cantele F, Zampighi L, et al. JUST (Java user segmentation tool) for semi-automatic segmentation of tomographic maps. J Struct Biol 2008; 161:287-289
37. Kamel IR, Kruskal JB, Warmbrand G, Goldberg SN, Pomfret EA, Raptopoulos V. Accuracy of volumetric measurements after virtual right hepatectomy in potential donors undergoing living adult liver transplantation. AJR 2001; 176:483-487 (Pubitemid 32105666)
38. Park Y, Choi D, Lim HK, et al. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT. AJR 2008; 191:215-220 (Pubitemid 351955191)
39. Herber S, Biesterfeld S, Franz U, et al. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 2008; 31:768-777
40. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006; 17:505-512
41. Zhao JG, Feng GS, Kong XQ, et al. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World J Gastroenterol 2004; 10:1152-1156
42. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR 2009; 193:1044-1052